Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis. [PDF]
Prakash V, Goel N.
europepmc +1 more source
Authors' Response to "Comment on 'SMPDL3B as a novel biomarker and therapeutic target in myalgic encephalomyelitis'". [PDF]
Rostami-Afshari B +3 more
europepmc +1 more source
<i>In Vivo</i> and <i>In Silico</i> Analysis of Quercetin's Effects on Glycemic Regulation. [PDF]
Jumriani J +11 more
europepmc +1 more source
Efficacy and Safety of Once-Weekly Trelagliptin As Compared to Twice-Daily Vildagliptin in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Phase 3, Non-inferiority Clinical Trial. [PDF]
Dewan B, Shinde S, Roy S.
europepmc +1 more source
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]
Rostami-Afshari B +12 more
europepmc +1 more source
Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. [PDF]
Sedik AA +3 more
europepmc +1 more source
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. [PDF]
Alfonso Arvez MJ +4 more
europepmc +1 more source
Unusual Presentation of Bullous Pemphigoid as Erythroderma in an Elderly Male. [PDF]
Thind A, Stephen, Singh A, Kaur S.
europepmc +1 more source
Identification, Isolation and Structural Elucidation of New Inner Salt Impurity in Vildagliptin and Metformin Tablet by Using Supercritical Fluid Chromatography, NMR, HRMS. [PDF]
Meganathan SK +4 more
europepmc +1 more source
Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes. [PDF]
Jimoh AO +6 more
europepmc +1 more source

